PatternsRadar
Sign in

JBCHEPHARMJBCHEPHARM

NSE
2,408.90INR-97.10 (-3.87%)Close · 16 Jul 2026
11 May 2026Last results
—Sector
—Industry
₹38,677 CrMarket cap
54.5P/E (TTM)
66.8%Delivery

Filings & corporate actions

77 results filed
CSV
Next results · Q1 FY27
Due — expected by 13 Aug 2026
Estimate: filed 30–44 days after quarter end, last 5 times
Dividend
₹9.30 per share · last 29 May 2026
2026
  • 29 MaydividendDividend · ₹9.30 per share-1.7%
  • 11 MayresultsResults · Q4 FY26 · consolidated and standalone-3.3%NSE
  • 16 AprshareholdingShareholding · 31 Mar 2026-0.3%NSE
  • 11 FebdividendDividend · ₹12.70 per share-1.5%
  • 31 JanshareholdingShareholding · 23 Jan 2026+0.3%NSE
  • 16 JanresultsResults · Q3 FY26 · consolidated and standalone+1.2%NSE
  • 6 JanshareholdingShareholding · 31 Dec 2025+2.1%NSE

Reaction to results · all yearsrose on day 0 in 40 of 77 CSV

QuarterFiledDay 0+5D+20DRel vol
Q4 FY2611 May 2026-3.3%-1.7%-0.3%2.4×
Q3 FY2616 Jan 2026+1.2%-1.4%+3.9%1.6×
Q2 FY2611 Nov 2025-0.5%-4.2%-1.0%1.4×
Q1 FY2630 Jul 2025-0.7%-5.2%-3.2%0.6×
Q4 FY2514 May 2025+1.6%+4.5%+8.2%0.9×
Q3 FY255 Feb 2025-1.6%-6.7%-8.6%2.1×
Q2 FY256 Nov 2024-1.1%-10.6%-5.2%1.0×
Q1 FY258 Aug 2024-0.9%-0.2%-0.5%1.1×
Q4 FY2418 May 2024+1.0%-2.4%-1.3%0.3×
Q3 FY247 Feb 2024+4.3%-2.9%-9.1%19.7×
Q2 FY248 Nov 2023+0.7%+4.2%+3.1%1.5×
Q1 FY2410 Aug 20230.0%-1.6%+2.6%3.2×
Q4 FY2325 May 2023+7.0%+10.3%+24.6%10.4×
Q3 FY239 Feb 2023-3.7%-3.6%-3.8%1.4×
Q2 FY2311 Nov 2022-0.6%+4.8%+3.5%1.1×
Q1 FY235 Aug 2022+0.5%-2.5%+1.9%1.4×
Q4 FY2227 May 2022+3.5%+1.0%-0.5%1.7×
Q3 FY2215 Feb 2022-1.4%-1.3%-4.8%1.7×
Q2 FY2212 Nov 2021+0.1%-5.1%-4.9%0.6×
Q1 FY2213 Aug 2021-0.3%-4.8%-2.8%2.7×
Q4 FY2115 Jun 2021+1.3%+2.5%+20.4%1.5×
Q3 FY2111 Feb 2021+0.4%-7.2%+0.6%2.5×
Q2 FY2111 Nov 2020-0.6%-2.3%+6.5%1.1×
Q1 FY2115 Sept 2020+8.3%+20.6%+25.7%8.0×
Q4 FY2026 Jun 2020-2.2%+3.7%+5.3%1.7×
Q3 FY205 Feb 2020+4.9%+13.9%+15.3%3.0×
Q2 FY2013 Nov 2019-0.3%-2.1%+5.5%2.7×
Q1 FY2013 Aug 2019+0.3%+1.5%+5.4%1.7×
Q4 FY1922 May 2019+5.7%+8.0%+7.8%19.4×
Q3 FY1913 Feb 2019+1.1%+3.7%+7.8%0.8×
Q2 FY1921 Nov 2018-1.0%-0.7%-0.3%0.4×
Q1 FY1927 Aug 2018+1.1%+3.6%-9.0%2.5×
Q4 FY1811 Jul 2018+0.2%+3.2%+8.4%0.5×
Q3 FY1828 Feb 2018-1.3%-3.9%-2.1%1.4×
Q2 FY1815 Nov 2017+0.1%0.0%+3.0%0.1×
Q1 FY1821 Aug 2017+0.2%-2.0%+1.8%1.6×
Q4 FY179 Jun 2017+0.9%+1.5%-6.7%0.5×
Q3 FY1717 Feb 2017+0.3%-0.5%+1.4%0.2×
Q2 FY1719 Nov 2016-7.4%-1.6%-0.5%3.3×
Q1 FY1722 Sept 2016-0.5%-5.6%+4.8%0.1×
Q4 FY1623 May 2016-3.3%+0.7%-6.0%1.3×
Q3 FY164 Feb 2016+0.3%-11.2%-1.6%2.2×
Q2 FY165 Nov 2015+0.5%+1.3%-1.0%0.4×
Q1 FY167 Aug 2015+2.0%+5.3%+3.6%0.8×
Q4 FY1521 May 2015+2.5%0.0%-5.8%3.5×
Q3 FY155 Feb 2015+1.4%+4.1%+3.2%7.8×
Q2 FY1519 Nov 2014-1.6%+1.2%-5.3%0.7×
Q1 FY1511 Aug 2014+12.0%+13.7%+31.0%5.1×
Q4 FY1427 May 2014-6.7%-7.0%-4.4%1.3×
Q3 FY1412 Feb 2014+1.8%-2.0%+0.1%5.3×
Q2 FY145 Nov 2013-0.4%+8.2%+10.4%1.2×
Q1 FY1429 Jul 2013-3.5%-6.0%+5.0%0.7×
Q4 FY1327 May 2013-2.5%-3.7%-11.5%0.4×
Q3 FY136 Feb 2013+1.6%-5.5%-6.2%8.6×
Q2 FY132 Nov 2012+1.6%+15.4%+18.1%1.8×
Q1 FY136 Aug 2012-3.4%-7.5%-8.2%1.4×
Q4 FY1230 May 2012+1.6%+3.6%+4.4%0.6×
Q3 FY1225 Jan 2012-2.4%-7.2%-2.4%8.9×
Q2 FY1219 Oct 2011+1.4%-2.0%-13.0%4.0×
Q1 FY1229 Jul 2011+2.8%-4.3%-33.5%0.8×
Q4 FY1124 May 2011-0.1%-1.8%-0.6%7.1×
Q3 FY1113 Jan 2011-2.5%-8.2%-24.9%1.8×
Q2 FY1126 Oct 2010+4.8%+7.2%-0.4%5.3×
Q1 FY1129 Jul 2010-3.2%-4.9%+3.6%1.1×
Q4 FY106 May 2010-4.5%-10.8%-14.3%3.2×
Q3 FY1028 Jan 2010+1.8%+7.5%+5.2%0.6×
Q2 FY1026 Oct 2009-5.4%-7.3%-4.1%1.0×
Q1 FY1021 Jul 2009+0.9%+3.3%+8.5%2.0×
Q4 FY0912 May 2009-3.1%+5.7%+8.0%2.9×
Q3 FY0922 Jan 20090.0%-2.2%-7.7%3.7×
Q2 FY0920 Oct 2008+20.1%+13.6%+8.4%4.3×
Q1 FY0925 Jul 2008+13.8%+11.2%+12.5%8.4×
Q4 FY089 May 2008-3.1%-9.0%-18.8%0.4×
Q3 FY0829 Jan 2008-5.9%-9.7%-7.5%0.1×
Q2 FY0830 Oct 2007+6.6%+0.8%+0.3%3.1×
Q1 FY0828 Jul 2007-2.1%-5.6%+1.5%1.7×
Q4 FY0717 May 2007-3.5%-9.2%-9.2%3.9×
Average+0.5%-0.2%+0.5%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q4 FY26

Revenue YoY-4.8%
Profit YoY-30.4%
Interest cost YoY-52.5%
Revenue QoQ-15.1%
Profit QoQ-48.8%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+9.1%+9.6%+14.4%+15.2%+15.2%—
Profit+13.3%+20.1%+16.5%+9.6%+17.3%—

Key data

Open2,506.00
Day range2,380.00 – 2,525.50
52-week range1,603.50 – 2,525.50
From 52w high-4.6%
RSI (14)61.0
ATR (14)59.79
Volume47.79L
Avg volume (20D)6.37L
Rel volume7.50×
Volatility (1Y)20.6%
Turnover₹1,151.3Cr
Traded value (NSE)—
VWAP—
SMA 50 / 2002,241.45 / 1,965.87

Delivery percentage

Latest · 16 Jul 202666.8%
20-day avg62.4%
1-year avg60.7%
Percentile (own history)66th
Range12.8–98.2%
Sessions3,541

Over the last 20 sessions JBCHEPHARM settled 62.4% of its traded quantity, which is unusually high for an NSE equity. That is in line with its own one-year average of 60.7%. The latest session ranks higher than 66% of the 3,541 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield1.20%
Dividend, trailing 12M₹29.00
Paid every year for10+ yr
Shareholders74.0K · +7.4% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy476 days ago

Performance returns

1D1W1M3M6M1Y
Price-3.87%-1.46%+9.85%+21.59%+26.05%+48.20%

Valuation

Market cap₹38,677 Cr
Free-float cap₹19,803 Cr
P/E (TTM)54.5
P/E (NSE)56.7
EPS (TTM)44.19
P/B9.3
Net margin (TTM)17.1%
Other income / PBT6.3%
ROE18.7%
Debt / equity0.00
Shares outstanding16.06Cr
Listed—

Ownership

Promoter48.80%
Promoter Δ QoQ+0.02 pp
Public51.20%
FII16.33%
DII21.38%
Pledged0.00%

Quarterly results · consolidated

Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue (₹ Cr)1,093.91,084.91,064.7904.2
YoY chg+8.9%+8.4%+10.5%-4.8%
Net profit (₹ Cr)202.4207.8197.9101.4
YoY chg+14.4%+19.0%+21.8%-30.4%
Net margin18.5%19.2%18.6%11.2%
EPS12.7513.0812.456.32

Shareholding over time

By quarter

31 Mar 2026 · promoter 48.80% · public 51.20%
30 Sept 2021: promoter 55.91%31 Dec 2021: promoter 54.00%31 Mar 2022: promoter 54.00%30 Jun 2022: promoter 54.00%30 Sept 2022: promoter 53.96%31 Dec 2022: promoter 53.95%31 Mar 2023: promoter 53.93%30 Jun 2023: promoter 53.91%30 Sept 2023: promoter 53.86%31 Dec 2023: promoter 53.83%31 Mar 2024: promoter 53.78%30 Jun 2024: promoter 53.77%30 Sept 2024: promoter 53.74%31 Dec 2024: promoter 53.66%31 Mar 2025: promoter 47.84%30 Jun 2025: promoter 47.73%30 Sept 2025: promoter 47.56%31 Dec 2025: promoter 47.55%23 Jan 2026: promoter 48.78%31 Mar 2026: promoter 48.80%
2021-092026-03
  • Promoter
  • Public and others
Promoter
48.80%
Public
51.20%
Promoter change
+0.02 pp
Filed
16 Apr 2026
FII
16.33%
DII
21.38%
Promoter pledged
0.00%

Who the public is

Mutual funds
19.00%

-0.22 pp QoQ

Insurance
1.33%

-0.59 pp QoQ

FPI
16.33%

+1.78 pp QoQ

Retail ≤ ₹2L
11.04%

-0.07 pp QoQ

HNI > ₹2L
0.73%

-0.19 pp QoQ

NRI
0.50%

-0.02 pp QoQ

Bodies corporate
0.56%

-0.19 pp QoQ

Shareholders
74,043

+7.4% QoQ

Major holders

As of 31 Mar 2026
HolderTypeHolding
TORRENT PHARMACEUTICALS LIMITEDPromoter · Corporate48.80%
KOTAK MIDCAP FUNDMutual fund4.40%
AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND A/C AXIS SMALL CAP FUNDMutual fund3.81%
CANARA ROBECO MUTUAL FUND A/C CANARA ROBECO SMALL CAP FUNDMutual fund2.17%
GOVERNMENT PENSION FUND GLOBALFPI1.84%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHARMA FUNDMutual fund1.60%
SMALLCAP WORLD FUND, INCFPI1.30%
FRANKLIN INDIA SMALL CAP FUNDMutual fund1.26%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 19 Jul 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹9.30₹9.30
FY2025-262₹19.70₹19.70
FY2024-252₹15.25₹15.25
FY2023-242₹14.75₹10.13
FY2022-232₹16.50₹8.25
FY2021-222₹16.50₹8.25
FY2020-212₹9.50₹4.75
FY2019-202₹15.00₹7.50
FY2018-191₹2.00₹1.00
FY2017-181₹1.00₹0.50
FY2016-171₹0.50₹0.25
FY2015-162₹18.50₹9.25
FY2014-151₹3.00₹1.50
FY2013-141₹3.00₹1.50
FY2012-131₹1.00₹0.50
Ex-dateRecord dateDeclaredAdjusted
29 May 2026—₹9.30₹9.30
11 Feb 2026—₹12.70₹12.70
30 Jul 2025—₹7.00₹7.00
7 Feb 2025—₹8.50₹8.50
14 Aug 2024—₹6.75₹6.75
16 Feb 2024—₹5.50₹5.50
17 Aug 2023—₹9.25₹4.63
17 Feb 2023—₹8.50₹4.25
12 Aug 2022—₹8.00₹4.00
23 Feb 2022—₹8.50₹4.25
1 Sept 2021—₹8.00₹4.00
18 Feb 2021—₹8.50₹4.25
22 Sept 2020—₹1.00₹0.50
3 Mar 2020—₹10.00₹5.00
14 Aug 2019—₹5.00₹2.50
27 Aug 2018—₹2.00₹1.00
11 Sept 2017—₹1.00₹0.50
11 Aug 2016—₹0.50₹0.25
17 Mar 2016—₹4.50₹2.25
6 Aug 2015—₹14.00₹7.00
4 Sept 2014—₹3.00₹1.50
1 Aug 2013—₹3.00₹1.50
19 Jul 2012—₹1.00₹0.50

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
5.4 years ago
Disclosures on record
1,127
2 open-market of the newest 100
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
29 Jun 2026Parmeshwar Bhawarlalji BangEmployeeSell1.3K₹29.2L2,245.627.0K → 5.7K0.00%0.00 pp7(2)told 26 Jun 2026
19 Mar 2026Sujay Kamlakar RajhansEmployeeSell11.8K₹2.5Cr2,110.0011.8K → —0.00%7(2)told 19 Mar 2026

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 27 Mar 2025

CSV
12 of 13 deals
By year
DateDealClientQuantityPriceValue
27 Mar 2025Sell · bulkTAU INVESTMENT HOLDINGS PTE LIMITED22.46L1,625.34₹365.0Cr
27 Mar 2025Sell · bulkTAU INVESTMENT HOLDINGS PTE LIMITED22.46L1,625.01₹364.9Cr
27 Mar 2025Sell · bulkTAU INVESTMENT HOLDINGS PTE LIMITED22.46L1,625.00₹364.9Cr
27 Mar 2025Sell · bulkTAU INVESTMENT HOLDINGS PTE LIMITED22.46L1,625.00₹364.9Cr
27 Mar 2025Buy · bulkKOTAK MAHINDRA MUTUAL FUND12.31L1,625.00₹200.0Cr
18 Sept 2020Buy · bulkTHE VANGUARD GROUP INC A/C VANGUARD EMERG. MKTS STOCK INDEXFD A SERIES OF V I E I F7.07L1,121.89₹79.3Cr
2 Nov 2017Sell · bulkASHISH DHAWAN4.72L289.54₹13.7Cr
1 Nov 2017Buy · bulkICICI LOMBARD GENERAL INSURANCE CO LIMITED20.00L288.00₹57.6Cr
1 Nov 2017Sell · bulkASHISH DHAWAN19.52L288.12₹56.2Cr
25 Oct 2017Sell · bulkKOTAK MAHINDRA ASSET MANAGEMENT CO LTD (SSV2 -SELL CODE) PM6.01L280.00₹16.8Cr
19 Aug 2011Sell · bulkCROSSEAS CAPITAL SERVICES PVT. LTD.4.60L139.49₹6.4Cr
19 Aug 2011Buy · bulkCROSSEAS CAPITAL SERVICES PVT. LTD.4.60L139.12₹6.4Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to JBCHEPHARM.

not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q1 FY24Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue from operations896.2881.7844.5861.71,004.41,000.6963.5949.51,093.91,084.91,064.7904.2
Other income5.67.77.416.65.910.08.014.514.615.318.312.0
Total income901.8889.4851.9878.41,010.31,010.6971.5964.01,108.51,100.21,083.0916.2
Total expenses707.5680.7667.9713.8770.5774.0753.5770.9836.9821.1816.1754.3
└ Finance costs12.110.412.59.45.62.12.61.51.11.41.91.2
└ Depreciation31.432.234.040.740.841.941.946.442.744.445.450.0
Profit before tax194.3208.7184.0164.6239.8236.5218.0193.0271.6279.2266.9134.7
Tax expense52.058.150.438.463.062.055.547.369.271.369.033.3
Net profit142.3150.6133.6126.2176.8174.6162.5145.7202.4207.8197.9101.4
EPS9.209.728.628.2211.3911.2410.469.3612.9913.2912.636.35
Net margin15.88%17.08%15.82%14.64%17.61%17.45%16.86%15.34%18.50%19.16%18.59%11.21%
PBT margin21.68%23.66%21.78%19.10%23.88%23.64%22.63%20.33%24.83%25.73%25.06%14.90%
Tax rate26.75%27.83%27.39%23.35%26.27%26.20%25.46%24.52%25.49%25.55%25.85%24.74%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 11 May 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 H1 FY23FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26
Total assets3,206.73,553.93,799.23,994.14,029.44,273.84,712.44,968.7
Current assets1,540.81,554.81,777.91,868.31,928.61,934.52,566.92,946.0
└ Cash & equivalents84.776.991.688.289.9115.193.8110.2
└ Other bank balances6.01.91.67.37.614.410.535.7
└ Current investments106.1192.2300.1364.7319.4317.1489.8738.9
└ Trade receivables646.3575.8714.7686.9816.5815.4937.7780.9
└ Inventories444.5430.5424.5502.5543.7529.0576.6683.4
Total equity2,315.32,480.42,716.72,923.33,212.23,433.33,805.74,159.2
└ Attributable to owners2,315.32,480.42,716.72,923.33,212.23,433.33,805.74,159.2
└ Non-controlling interest0.0———0.0———
└ Share capital15.515.515.515.515.515.615.716.1
Borrowings350.1548.2427.1357.181.613.87.30.0
└ Current118.0165.0148.0333.581.613.87.30.0
└ Non-current232.1383.2279.123.60.00.00.00.0
Trade payables254.0238.6322.4356.3342.5410.7409.7391.0
Current liabilities556.2554.5642.7868.2621.9632.3674.2591.2
Total liabilities891.41,073.51,082.51,070.8817.2840.5906.7809.4
Net debt153.2277.333.8(103.1)(335.2)(432.8)(586.8)(884.8)
Debt / equity0.150.220.160.120.030.000.000.00
Current ratio2.772.802.772.153.103.063.814.98

Cash flow, year to date

 H1 FY23FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26
Operating cash flow381.6625.6421.6800.6377.6902.5362.4703.9
└ Capex(378.9)(765.0)(93.1)(261.4)(49.1)(120.3)(47.0)0.0
Free cash flow2.7(139.3)328.5539.3328.6782.2315.4703.9
Investing cash flow(495.0)(961.8)(192.6)(403.8)9.6(295.9)(297.5)(585.9)
Financing cash flow244.0356.5(214.3)(385.5)(385.5)(579.7)(86.4)(123.1)
└ Dividends paid(61.8)(127.6)(71.7)(157.0)(104.8)(237.0)(109.4)(313.3)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash130.620.414.711.31.726.9(21.3)(4.9)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

JBCHEPHARM at a glance

  • JBCHEPHARM closed at ₹2,408.9 on 16 Jul 2026, -3.87% on the day, +48.2% over one year, 4.6% below its 52-week high of ₹2,525.5.
  • Delivery was 66.8% of traded quantity on 16 Jul 2026, the 66th percentile of its own 3,541 sessions with a reading (20-session average 62.4%, 1-year average 60.7%).
  • Market capitalisation is ₹38,677 crore at a trailing P/E of 54.5 (trailing EPS ₹44.19).
  • Q4 FY26 results (consolidated, filed 11 May 2026): revenue ₹904 crore (-4.8% year on year), net profit ₹101 crore (-30.4%); the price moved -3.3% on the first session after.
  • Promoters held 48.80% at 31 Mar 2026, up 0.02 percentage points on the previous filing.
  • Q1 FY27 results are expected between 30 Jul 2026 and 13 Aug 2026, going by past filing dates — an estimate, not an announcement.

About

Macro sector—
Basic industry—
ISININE572A01036
SeriesEQ
Listed—
NSE market cap · 28 Aug 2026—
Free-float market cap (NSE)—
Shares outstanding (NSE)16.06Cr
History from2 Feb 1995
Sessions7,475

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.